Abstract
Objective: To investigate the effects of ginseng polysaccharides (GP) on hepatocellular energy metabolism in Hepatic Ischemia Reperfusion Injury (HIRI) of rabbits.
Introduction
Hepatic Ischemia Reperfusion Injury (HIRI) remains a significant clinical hurdle during liver transplantation, trauma, and major hepatic resections. The initial restriction of blood flow (ischemia) deprives the liver of oxygen, leading to a rapid decline in aerobic metabolism and ATP synthesis. Paradoxically, the restoration of blood flow (reperfusion) often exacerbates tissue damage through oxidative stress and inflammatory cascades. While the inflammatory aspects of HIRI are well-documented, this research focuses on the "energy metabolism gap"—the catastrophic depletion of high-energy phosphates that leads to cellular failure. This study investigates whether ginseng polysaccharides (GP) can serve as a metabolic stabilizer to mitigate this energy crash and preserve cellular integrity.
Methods
The researchers utilized a rabbit model (n=30) divided into three cohorts:
- Control (C): Sham surgery with no blood flow occlusion.
- Ischemia-Reperfusion (IR): 45 minutes of hepatic blood flow blockage followed by 45 minutes of reperfusion.
- Ginseng Polysaccharides (GP): Pretreated with 0.3 mg/kg of GP 10 minutes before the ischemia period.
Key techniques included High-Performance Liquid Chromatography (HPLC) for metabolic profiling of ATP, ADP, and AMP. The team calculated the Total Adenylic Acid Number (TAN) and Energy Charge (EC) to assess cellular energy status. Clinical indicators of damage were measured via plasma Alanine Aminotransferase (ALT), and sub-cellular structural changes were observed using Transmission Electron Microscopy (TEM).
Results and Discussion
Metabolic Stabilization and ATP Preservation
The study found that GP pretreatment significantly preserves cellular energy stores. In the IR group, ATP levels plummeted to 0.98 mg/g. However, pretreatment with GP kept ATP levels at 2.80 mg/g—nearly three times higher than the untreated group. This suggests that GP works by reducing the decomposition of existing ATP and facilitating its production even under ischemic stress.
A strong negative correlation (r = -0.629) was identified between ATP levels and plasma ALT, confirming that energy failure is a primary driver of the membrane leakage that releases ALT into the bloodstream. Furthermore, the Energy Charge (EC) in the IR group dropped to 0.34, while the GP group maintained an EC of 0.63, remarkably close to the control group’s 0.67. The accumulation of AMP (a sign of energy depletion) was also significantly lower in the GP group (1.50 mg/g) compared to the IR group (3.32 mg/g).
Structural Preservation
Ultrastructural analysis via TEM provided striking visual evidence of GP's protective effects. While the IR group showed hallmarks of injury such as vacuolized mitochondria and a loss of microvilli, the GP-treated group maintained nearly normal cellular architecture.
GP prevented the expansion of the "Disiens gap" and the swelling of the rough endoplasmic reticulum. These morphological improvements correlate with the metabolic data, suggesting that by maintaining structural integrity—particularly mitochondrial health—GP allows the cell's metabolic machinery to function more effectively during the critical reperfusion phase.
Conclusion
Ginseng polysaccharides act as a potent metabolic shield for the liver, significantly reducing tissue damage during ischemia-reperfusion by stabilizing ATP levels and preventing cellular energy failure. While promising, future work is needed to assess long-term recovery, optimize dosing, and elucidate the specific molecular pathways involved. Nonetheless, GP pretreatment offers a potential therapeutic strategy for improving outcomes in major hepatic surgeries and transplantations.
Summary updated